GSTM1 and nasopharyngeal carcinoma: A positive relationship between survival outcomes and Hb levels has been demonstrated in patients with NPC receiving RT ± chemotherapy: low pretreatment Hb was related to increased risk of death or metastasis 11, 12, 13, 14, 15.